IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • Journal of Experimental and Clinical Medicine
  • Volume:7 Issue:2
  • Negatif Pozitif Şizofreni

Negatif Pozitif Şizofreni

Authors : A ÖZKAN, AC ARIK
Pages : 0-0
Doi:10.5835/jecm.v7i2.1095
View : 36 | Download : 14
Publication Date : 2009-12-22
Article Type : Other Papers
Abstract :SUMMARY NEGATIVE AND POSITIVE SCHIZOPHRENIA To establish the characteristics and clinical significance of positive and negative schizophrenia which are considered as subtypes of schizophrenia twenty-six patients who met the DSM-III-R criteria for schizophrenic disorders were studied in two groups according to their symptoms. As a result of the study the two groups were found to have significant differences in regards to response to neuroleptic treatment, CT findings and family psychopathology. The significance of subtyping schizophrenia as positive and negative is emphasized. ÖZET Şizofrenik bozuklukların alt grubu olarak düşünülen pozitif ve negatif şizofreninin özellikleri ve klinik öneminin araş¬tırılması amaçlanan bu çalışmada, DSM-III-R kriterlerine gore şizofrenik. bozukluk tanısı alan 26 hasta semptomlarına göre iki grup halinde incelendi.. Çalışma sonucunda, iki grup arasında ilaca cevap, BBT bulguları ve ailede psiko¬patoloji açısından anlamlı farklılık saptandı ve pozitif ve negatif şizofreni ayrımının önemi vurgulandı.
Keywords :

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2026